# Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

> **NCT00598078** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 19 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** Sodium Oxybate
- **DRUG:** Sodium Oxybate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00598078
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598078, "Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00598078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*